Back to Search Start Over

PD-1 and PD-L1 expression in cardiac transplantation.

Authors :
Bishawi M
Bowles D
Pla MM
Oakes F
Chiang Y
Schroder J
Milano C
Glass C
Source :
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology [Cardiovasc Pathol] 2021 Sep-Oct; Vol. 54, pp. 107331. Date of Electronic Publication: 2021 Mar 16.
Publication Year :
2021

Abstract

Programmed death-ligand 1 (PD-L1), a transmembrane protein and member of the CD28 T cell family is associated with lymphocyte activation. <superscript>1</superscript> PD-L1 expression is upregulated on activated antigen presenting cells such as monocytes, myeloid and dendritic cells. <superscript>2</superscript> When bound to its cognate receptor programmed cell death (PD-1), inhibition of immune responses including downregulation of T cell proliferation occurs. <superscript>3</superscript> Mechanistically, such inhibition would be hypothetically favorable in the setting of a transplanted organ undergoing allograft rejection. However, there is a paucity of data addressing the role of PD-L1 and PD-1 expression in the human transplanted heart.<br /> (Copyright © 2021 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1879-1336
Volume :
54
Database :
MEDLINE
Journal :
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Publication Type :
Academic Journal
Accession number :
33737091
Full Text :
https://doi.org/10.1016/j.carpath.2021.107331